S&S Healthcare Holding (ROCO:4198) Cyclically Adjusted FCF per Share: NT$-18.85 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ROCO:4198 S&S Healthcare Holding Ltd ROCO:4198
47 GF Score
Price NT$40.10
GF Value NT$22.09
Valuation Significantly Overvalued
! 1 Warning Sign
View Full Analysis

What is S&S Healthcare Holding Cyclically Adjusted FCF per Share?

S&S Healthcare Holding ROCO:4198 -0.62% 47 Cyclically Adjusted FCF per Share is NT$-18.85 as of Mar. 2026. GuruFocus rates ROCO:4198 with a GF Score™ of 47/100 and a GF Value™ of NT$22.09 (Significantly Overvalued). The stock has 1 warning sign investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

S&S Healthcare Holding's adjusted free cash flow per share for the three months ended in Mar. 2026 was NT$-0.936. Add all the adjusted free cash flow per share for the past 10 years together and divide the count will get our Cyclically Adjusted FCF per Share, which is NT$-18.85 for the trailing ten years ended in Mar. 2026.

During the past 3 years, the average Cyclically Adjusted FCF Growth Rate was 21.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted FCF Growth Rate using Cyclically Adjusted FCF per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted FCF Growth Rate of S&S Healthcare Holding was 21.60% per year. The lowest was 21.60% per year. And the median was 21.60% per year.

As of today (2026-08-04), S&S Healthcare Holding's current stock price is NT$40.10. S&S Healthcare Holding's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2026 was NT$-18.85. S&S Healthcare Holding's Cyclically Adjusted Price-to-FCF of today is .


S&S Healthcare Holding  (ROCO:4198) Cyclically Adjusted FCF per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted FCF per Share may underestimate the company's free cash flow. Cyclically Adjusted Price-to-FCF can seem to be too high even the actual Price-to-Free-Cash-Flow is low.

For the Cyclically Adjusted Price-to-FCF, the free cash flow per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/FCF calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted Price-to-FCF is also called CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.


Be Aware

Cyclically Adjusted Price-to-FCF works better for cyclical companies. It gives you a better idea on the company's real free cash flow value.


S&S Healthcare Holding Cyclically Adjusted FCF per Share Related Terms


S&S Healthcare Holding Cyclically Adjusted FCF per Share Historical Data

* Premium members only.

The historical data trend for S&S Healthcare Holding's Cyclically Adjusted FCF per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

S&S Healthcare Holding Cyclically Adjusted FCF per Share Chart

S&S Healthcare Holding Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted FCF per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 -40.77 -38.36 -27.50 -19.66

S&S Healthcare Holding Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted FCF per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -24.56 -22.77 -22.19 -19.66 -18.85

ROCO:4198 vs ABT, SYK, MDT: Cyclically Adjusted FCF per Share Comparison

For the Medical Devices subindustry, S&S Healthcare Holding's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


S&S Healthcare Holding Cyclically Adjusted Price-to-FCF vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, S&S Healthcare Holding's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where S&S Healthcare Holding's Cyclically Adjusted Price-to-FCF falls into.


ROCO:4198
47GF Score
S&S Healthcare Holding Ltd ROCO:4198
Cyclically Adjusted FCF per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

S&S Healthcare Holding Cyclically Adjusted FCF per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

What is Cyclically Adjusted FCF per Share? How do we calculate Cyclically Adjusted FCF per Share?

Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted FCF per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the free cash flow per share from 2001 through 2010.

We adjusted the 2001 free cash flow per share data with the total inflation from 2001 through 2010 to the equivalent free cash flow in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's free cash flow is $1 a share in 2001, then the 2001's equivalent free cash flow in 2010 is $1.4 a share. If Wal-Mart's free cash flow is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 free cash flow in 2010 is $1.35. So on and so forth, you get the equivalent free cash flow per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, S&S Healthcare Holding's adjusted Free Cash Flow per Share data for the three months ended in Mar. 2026 was:

Adj_FreeCashFlowPerShare= Free Cash Flow per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=-0.936/330.2130*330.2130
=-0.936

Current CPI (Mar. 2026) = 330.2130.

S&S Healthcare Holding Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201606 -14.674 241.018 -20.104
201609 -9.489 241.428 -12.979
201612 -17.087 241.432 -23.370
201703 -17.553 243.801 -23.774
201706 -8.684 244.955 -11.707
201709 -10.312 246.819 -13.796
201712 -11.469 246.524 -15.362
201803 -4.637 249.554 -6.136
201806 -6.145 251.989 -8.053
201809 -4.369 252.439 -5.715
201812 -0.902 251.233 -1.186
201903 -5.949 254.202 -7.728
201906 -2.474 256.143 -3.189
201909 0.264 256.759 0.340
201912 -2.436 256.974 -3.130
202003 -1.713 258.115 -2.191
202006 -1.629 257.797 -2.087
202009 -0.164 260.280 -0.208
202012 -2.123 260.474 -2.691
202103 -1.493 264.877 -1.861
202106 -1.504 271.696 -1.828
202109 -0.544 274.310 -0.655
202112 -1.726 278.802 -2.044
202203 -5.222 287.504 -5.998
202206 -1.984 296.311 -2.211
202209 -0.719 296.808 -0.800
202212 -0.578 296.797 -0.643
202303 -1.456 301.836 -1.593
202306 -0.639 305.109 -0.692
202309 -1.350 307.789 -1.448
202312 -0.873 306.746 -0.940
202403 -1.915 312.332 -2.025
202406 -1.348 314.175 -1.417
202409 -0.313 315.301 -0.328
202412 1.041 315.605 1.089
202503 -0.953 319.799 -0.984
202506 0.192 322.561 0.197
202509 -0.195 324.800 -0.198
202512 -0.155 324.054 -0.158
202603 -0.936 330.213 -0.936

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

What does a Cyclically Adjusted FCF per Share of NT$-18.85 mean?
S&S Healthcare Holding (ROCO:4198) has a Cyclically Adjusted FCF per Share of NT$-18.85 as of Mar. 2026. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on S&S Healthcare Holding and its competitors.
Is S&S Healthcare Holding's Cyclically Adjusted FCF per Share too high?
S&S Healthcare Holding's current Cyclically Adjusted FCF per Share is NT$-18.85. Overall, S&S Healthcare Holding has a GF Score™ of 47/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does S&S Healthcare Holding's Cyclically Adjusted FCF per Share compare to ABT and SYK?
S&S Healthcare Holding's Cyclically Adjusted FCF per Share of NT$-18.85 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted FCF per Share for a Medical Devices & Instruments company?
A good Cyclically Adjusted FCF per Share depends on the Medical Devices & Instruments industry context. However, Cyclically Adjusted FCF per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted FCF per Share mean?
A high Cyclically Adjusted FCF per Share can signal that a stock is expensive relative to its fundamentals. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on S&S Healthcare Holding and its competitors. S&S Healthcare Holding's current Cyclically Adjusted FCF per Share is NT$-18.85. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is S&S Healthcare Holding stock overvalued right now?
Based on GuruFocus' analysis, S&S Healthcare Holding (ROCO:4198) is currently considered Significantly Overvalued. The stock's GF Value™ is NT$22.09, compared to a current price of NT$40.10 — trading 81.5% above its estimated fair value. The current Cyclically Adjusted FCF per Share is NT$-18.85. S&S Healthcare Holding's overall GF Score™ is 47/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted FCF per Share calculated?
Cyclically Adjusted FCF per Share is calculated from a company's financial statements. For S&S Healthcare Holding (ROCO:4198), the current Cyclically Adjusted FCF per Share is NT$-18.85 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is S&S Healthcare Holding (ROCO:4198) Overvalued in 2026?

Based on GuruFocus' analysis, S&S Healthcare Holding stock appears to be overvalued. The current stock price of NT$40.10 is trading 81.5% above its estimated GF Value™ of NT$22.09. GuruFocus considers S&S Healthcare Holding to be Significantly Overvalued.

Key valuation signals for ROCO:4198:

  • Cyclically Adjusted FCF per Share: NT$-18.85
  • GF Value™: NT$22.09 vs. price of NT$40.10 (81.5% above fair value)
  • GF Score™: 47/100 with 1 warning sign

No single metric tells the full story. See the ROCO:4198 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


S&S Healthcare Holding Business Description

Address 7th Floor, Number 89, Xinhu 1st Road, Taipei, TWN, 114
S&S Healthcare Holding Ltd, formerly Swissray Global Healthcare Holding Ltd is involved in providing DR systems designed for any application in general radiography. The product divisions of the company cover Swissray DDR systems, Novadaq, and EZ2GO. The main business projects of the company and its subsidiaries are the research and development, manufacturing, sales, and maintenance services of high-end medical equipment and the manufacturing and sales of basic medical equipment.
47GF Score

Get the complete analysis for ROCO:4198

Cyclically Adjusted FCF per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$40.10
Price
NT$22.09
GF Value